References
- Eren E, Küçükerdönmez C, Yilmaz G, Akova YA. Regression of neovascular posterior capsule vessels by intravitreal bevacizumab. J Cataract Refract Surg. 2007;33(6):1113–1115. doi:10.1016/j.jcrs.2007.01.040.
- Ha JY, Lee TH, Sung MS, Park SW. Efficacy and safety of intracameral bevacizumab for treatment of neovascular glaucoma. Korean J Ophthalmol. 2017;31(6):538–547. doi:10.3341/kjo.2017.0017.
- Hwang YS, Lai CC, Lee JS, Yang KJ, Chen TL. Posttraumatic neovascularization in a cataractous crystalline lens. J Cataract Refract Surg. 2002;28:715–716.
- Walkden A, Tan SZ, Au L, Mercieka K. Vascularisation of the anterior lens capsule in an eye with excellent visual acuity. BMJ Case Rep. 2017;6:bcr-2017–220163. doi:10.1136/bcr-2017-220163.
- Gupta S, Gogia V, Ramya A, Sihota R. Capsular neovascularisation: case report and review of literature. Eye (Lond). 2014;28(3):358–359. doi:10.1038/eye.2013.298.
- Khokhar S, Ganguly A, Gupta S, Sen S. Fugo blade-assisted lens aspiration in a case of intra- and retro-lenticular hemorrhage. Int Ophthalmol. 2013;33(1):5–7. doi:10.1007/s10792-012-9663-9.
- Sinapis CI1, Routsias JG, Sinapis AI. et al. Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits. Clin Ophthalmol. 2011;5:697–704. doi:10.2147/OPTH.S19555.
- Kastner C, Lobler M, Reske T, Smidtz K-P. Determination of human anterior lens capsule permeability for fluorescent model substances and after-cataract preventive drugs. Biomed Eng. 2012;57:561–563. doi:10.1515/bmt-2012-4340.
- Kastner C, Lobler M, Sternberg K, et al. Permeability of the anterior lens capsule for large molecules and small drugs. Curr Eye Res. 2013;38(10):1057–1063.doi:10.3109/02713683.2013.803288.
- Jun JH, Sohn WJ, Lee Y, Kim JY. Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells. Clin Ophthalmol. 2016;27(10):1167–1174. doi:10.2147/OPTH.S103443.
- Sora D, Takayama K, Taguchi M, et al. Topical corticosteroid-resolved rubeosis iridis with neovascular glaucoma caused by noninfectious granulomatous uveitis. Case Rep Ophthalmol. 2018; 28;9(1):243–247. doi:10.1159/000488137.
- Gulati N, Forooghian F, Lieberman R, Jabs DA. Vascular endothelial growth factor inhibition in uveitis: a systematic review. Br J Ophthalmol. 2011;95(2):162–165. doi:10.1136/bjo.2009.177279.
- Fine HF, Baffi J, Reed GF, Csaky KG, Nussenblatt RB. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol. 2001;132(5): 794–796.
- Gupta S, Gogia V,TR, Sen S, Venkatesh P. Posterior lens capsular neovascularization of young: management using endodiathermy assisted biopsy. Can J Ophthalmol. 2015;50(1):e4–7. doi:10.1016/j.jcjo.2014.10.011.